Drug Description in Trials / DrugBank / KEGG DRUG


Search results


No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1Tibulizumab
(D11127)
[1] Tibulizumab[1] Tibulizumab (D11127) 💬[2] IL17A,
TNFSF13B 💬
[8] Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis, Th17 cell differentiation 💬[1] 53 💬
2Tibulizumab (LY3090106)
(D11127)
[1] Tibulizumab[1] Tibulizumab (D11127) 💬[2] IL17A,
TNFSF13B 💬
[8] Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis, Th17 cell differentiation 💬[1] 53 💬